Comerica Bank’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-503
Closed -$2.41K 3768
2024
Q4
$2.41K Sell
503
-504
-50% -$2.41K ﹤0.01% 3454
2024
Q3
$4.72K Hold
1,007
﹤0.01% 3348
2024
Q2
$5.69K Hold
1,007
﹤0.01% 3279
2024
Q1
$4.14K Sell
1,007
-25
-2% -$103 ﹤0.01% 3373
2023
Q4
$4.36K Hold
1,032
﹤0.01% 3358
2023
Q3
$4.46K Buy
1,032
+198
+24% +$855 ﹤0.01% 3391
2023
Q2
$75 Buy
+834
New +$75 0.01% 137
2022
Q4
$258K Sell
33,847
-9,509
-22% -$72.5K ﹤0.01% 1997
2022
Q3
$450K Sell
43,356
-4,715
-10% -$48.9K ﹤0.01% 1817
2022
Q2
$555K Buy
48,071
+365
+0.8% +$4.21K ﹤0.01% 1789
2022
Q1
$537K Buy
47,706
+1,180
+3% +$13.3K ﹤0.01% 1841
2021
Q4
$682K Sell
46,526
-55,941
-55% -$820K 0.01% 1739
2021
Q3
$1.72M Buy
102,467
+50,469
+97% +$848K 0.01% 1396
2021
Q2
$798K Sell
51,998
-3,400
-6% -$52.2K ﹤0.01% 1828
2021
Q1
$940K Sell
55,398
-2,155
-4% -$36.6K 0.01% 1780
2020
Q4
$817K Buy
57,553
+497
+0.9% +$7.06K 0.01% 1824
2020
Q3
$585K Sell
57,056
-51
-0.1% -$523 ﹤0.01% 1836
2020
Q2
$621K Buy
57,107
+5,424
+10% +$59K ﹤0.01% 1769
2020
Q1
$617K Buy
51,683
+1,609
+3% +$19.2K 0.01% 1628
2019
Q4
$651K Buy
50,074
+65
+0.1% +$845 ﹤0.01% 1778
2019
Q3
$686K Buy
50,009
+405
+0.8% +$5.56K 0.01% 1733
2019
Q2
$659K Sell
49,604
-2,238
-4% -$29.7K 0.01% 1753
2019
Q1
$928K Buy
51,842
+725
+1% +$13K 0.01% 1617
2018
Q4
$1.46M Buy
+51,117
New +$1.46M 0.01% 1315